ALL is clonally heterogeneous and genetic lesions in minor clones may confer resistance to therapy and promote disease relapse (e.g., TP53, IKZF1, CREBBP) [22]. The gene discussed is CREBBP; the disease is acute lymphoblastic leukemia.